Diarrhoea Digestive System Diarrhoea
Conditions
Interventions
This trial will be piloted in the three medical ward at the Friarage Hospital, Northallerton prior to extension to wards 3, 4 and 12 at James Cook University Hospital (SJUH). These three wards specia
the pharmacy will keep the key.
Patients will be provided with a 28-day course of the synergy 1. As synergy 1 is a food supplement and not a drug it will not be necessary for patients primary clinic
Sponsors
Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients isolated or barrier nursed as a result of diarrhoea 2. Have received antibiotics in the preceding week 3. Able to give informed consent
Exclusion criteria
Exclusion criteria: 1. Patients unable to give informed consent 2. Restricted oral intake 3. Those with diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to discontinuation of diarrhoea defined as greater than 3 loose stools in 24 hours. As would be standard clinical practice, all patients must have a baseline stool sample to check for C. difficile infection. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of clinical recurrence of C. difficile infection during the period of follow up. | — |
Countries
United Kingdom
Outcome results
None listed